TY  - CONF 
AU  - Lopez, J. M.
AU  - Alexandre, L. A.
AU  - Caldero, S. G.
AU  - Gonzales, A. N.
AU  - Lopez, P. S.
AU  - Bellvert, C. G.
AU  - Garcia, C. C.
AU  - Melgar, L.
AU  - Navarro, E. C.
AU  - Abdulkader Nallib, Ihab
AU  - Dongo, C. A. V.
AU  - Camin, M. S.
AU  - Hernando, A. Y.
AU  - Cuevas, L. A.
AU  - Pijuan, L.
AU  - Iglesias, T. H.
AU  - Pozo, A. M.
AU  - Anton, C. S.
PY  - 2019
SN  - 1556-0864
UR  - http://hdl.handle.net/20.500.11940/15670
AB  - Background
Oncogenic ALK gene rearrangements are found in approximately 4% of non-small cell lung cancer (NSCLC). Treatment options such as ALK tyrosine kinase inhibitors lead to improved progression free survival and overall survival. Thus,...
LA  - eng
TI  - Spanish Lung Cancer Biomarker Testing Registry (Lungpath): Descriptive Analysis Focus in ALK Traslocation Results
DO  - 10.1016/j.jtho.2019.08.2213
KW  - CHUS
VL  - 14
ER  -